Skip to main content

Table 2 Stepwise multivariate logistic regression to examine the association between blood pressure groups and diagnosis of cerebrovascular disease, transient ischemic attack and stroke

From: Prevalence of orthostatic hypertension and its association with cerebrovascular diagnoses in patients with suspected TIA and minor stroke

Outcomes/level of adjustment

Systolic orthostatic hypertension compared to No orthostatic hypertension

Diastolic orthostatic hypertension compared to No orthostatic hypertension

Combined systolic and diastolic orthostatic hypertension compared to No orthostatic hypertension

n

OR (95% CI)

n

OR (95% CI)

n

OR (95% CI)

Odds of CVD

      

Model A

3201

0.79 (0.57–1.08)

3201

0.87 (0.73–1.02)

3201

0.55 (0.35–0.87)

Model B

3103

0.79 (0.57–1.09)

3103

0.89 (0.75–1.06)

3103

0.56 (0.35–0.89)

Model C

3103

0.79 (0.57–1.09)

3103

0.89 (0.75–1.05)

3103

0.56 (0.36–0.90)

Model D

3103

0.79 (0.57–1.09)

3103

0.89 (0.75–1.05)

3103

0.56 (0.35–0.89)

Odds of stroke

      

Model A

3201

0.83 (0.55–1.26)

3201

1.08 (0.88–1.32)

3201

0.93 (0.53–1.62)

Model B

3103

0.82 (0.54–1.25)

3103

1.11 (0.90–1.36)

3103

0.90 (0.51–1.59)

Model C

3103

0.83 (0.54–1.26)

3103

1.11 (0.91–1.37)

3103

0.90 (0.51–1.59)

Model D

3103

0.83 (0.43–1.26)

3103

1.11 (0.90–1.36)

3103

0.89 (0.50–1.58)

Odds of TIA

      

Model A

3201

0.87 (0.62–1.22)

3201

0.81 (0.68–0.96)

3201

0.51 (0.30–0.87)

Model B

3103

0.87 (0.62–1.23)

3103

0.82 (0.68–0.98)

3103

0.54 (0.32–0.92)

Model C

3103

0.87 (0.62–1.23)

3103

0.81 (0.68–0.98)

3103

0.54 (0.32–0.93)

Model D

3103

0.87 (0.62–1.24)

3103

0.82 (0.68–0.98)

3103

0.54 (0.32–0.93)

  1. Model A: adjusted for age and sex
  2. Model B: adjusted for Model A and smoking, alcohol consumption, body mass index
  3. Model C: adjusted for Model B and previous stroke, transient ischemic attack, atrial fibrillation, hypertension, ischemic heart disease, peripheral vascular disease, diabetes and hyperlipidemia
  4. Model D: adjusted for Model C and use of thiazide, ACE inhibitor or ARB, beta-blocker, diuretic, calcium channel blocker and alpha blocker